OR WAIT null SECS
April 01, 2020
The new patented process results in uniform, scalable production and the ability to deliver cell cargo similar to natural exosomes/extracellular vesicles.
March 20, 2020
Emergent BioSolutions will help develop and manufacture an oral vaccine candidate and will develop plasma-based antibody therapeutics.
March 09, 2020
The new BIOSTAT STR Generation 3 with BIOBRAIN bioproduction platform offers process intensification with automated feed and bleed and integrated cell retention functionality.
March 05, 2020
The technology enables the rapid production of large numbers of recombinant antibodies at 80-mL scale.
March 02, 2020
Tackling process development early on can better optimize manufacturing processes for emerging therapies.
The growing interest in developing cell and gene therapies has prompted industry investment to grow manufacturing capacity.
February 27, 2020
The expansion gives the company diversified capacity running cell production lines featuring Sartorius-brand 2000-L disposable bioreactors and now GE-brand 2000-L single-use bioreactors.
The company presented data on its G2 glycosylation studies at the 15th European Conference on Fungal Genetics in Rome on Feb. 19, 2020.
February 14, 2020
The company has said that all three of its operating sites in China started back up on Feb. 12 and that it is closely monitoring the outbreak.
February 06, 2020
The new facility includes six classified environment rooms with space to expand.